The stock is extremely overextended (+35% in 1 week) with RSI >70 indicating overbought conditions. Current price ($36.02) exceeds the average analyst target ($34.09). While the Forward P/E (22.5) supports a long-term bullish thesis, the risk-reward ratio at these levels is poor. Strategy is to wait for a mean-reversion pullback to support at $33.74 before fresh capital deployment.